← Back to Clinical Trials
Recruiting NCT06248268

Neuropsychological Patterns of Suicide Ideators and Suicide Attempters

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Inhibitory Control
Sponsor University of Bern
Study Type OBSERVATIONAL
Phase N/A
Enrollment 180
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-08-08
Completion 2026-12-31
Interventions
(Neuro-)psychological assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The present study consists of 3 projects in total and aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the effects and feasibility of ASSIP Home Treatment. The overall aim of project 1 is to determine (neuro-) psychological differences between suicide attempters, suicide ideators, a clinical control group, and healthy controls. Study participants in project 1 will participate in a one-time (neuro-) psychological assessment. Project 1 of this study is an observational cross-sectional study with four groups that will be conducted at the University Hospital of Psychiatry and Psychotherapy Bern (Switzerland): Patients with at least one suicide attempt in their past (SUAT), patients with suicidal ideation (SUID), patients from the same clinical cohort, without neither suicidal behavior or ideation (CLIN) and the healthy group (HLTH). The cohorts to be examined (SUAT \& SUID) will be compared to the two control groups (CLIN \& HLTH). Only people who have signed the informed consent and meet the eligibility criteria can participate in this study.

Eligibility Criteria

Inclusion Criteria: Subjects fulfilling the following inclusion criteria are eligible for the study: * Informed consent as documented by signature * Age ≥ 18 years Additional inclusion criterion for the SUAT group in project 1: • At least one previous suicide attempt Additional inclusion criterion for the SUID group in project 1: • Suicidal ideation Additional inclusion criterion for the CLIN group in project 1: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis For the HLTH group, no further inclusion criteria are formulated. Exclusion Criteria: The presence of any one of the following exclusion criteria leads to exclusion of the subject: * Serious cognitive impairment * Any current psychotic disorder * Any current medication, which substantially impairs the attention span, reaction rate or any other relevant cognitive functions * Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment int

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}